Notice of postponement of ACTA 2020 TOKYO

ACTA 2020 TOKYO, which is scheduled to be held at Kioi Conference from October 9 (Fri) to October 11 (Sun), will be postponed.

As the threat of the novel coronavirus infection has not yet settled, the immigration restrictions will not be relaxed or lifted as of July or August. Therefore, it would be virtually impossible for overseas delegates to participate in ACTA 2020 TOKYO in October.

The date of the conference will be announced as soon as it is decided.

Thank you for your understanding and support.

Shuichiro Shiina
ACTA 2020 TOKYO Chairman
Professor of Department of Gastroenterology, Juntendo University

Welcome Message

Welcome Message from the Hosting Chairman

Shuichiro Shiina

It is my great honor to hold the 7th Asian Conference on Tumor Ablation (ACTA 2020 TOKYO) as the Chairman from October 9 to 11, 2020 at Kioi Conference, Tokyo, Japan.

ACTA is an annual forum for ablation specialists in Asia aimed at updating their knowledge and sharing experiences on all ablation techniques such as radiofrequency, microwave, and cryoablation. It also aims at discussing their applications not only for the liver but also for the lung, thyroid, kidney, bone, soft tissue, and all other organs.

Asia with the world’s largest population and the highest prevalence of liver cancer, is where the highest number of doctors perform the highest number of ablation procedures in the world’s largest market. The birthplace of ethanol and microwave ablations, Asia has led the world in techniques and experience. We hold the responsibility of leading the world into a new stage of ablation.

Ablation is used to treat many patients, especially those with cancer. Minimally invasive yet curative and cost-effective ablation will be required to play an even greater role in the health care of our aging societies.

The theme for ACTA 2020 TOKYO is “Lead the World.” We hope it will remind all participants of ACTA’s position in the international community as well as of the role of ablation in medical care going forward. We will invite numerous specialists from Japan and abroad to present their clinical experience and research outcomes, engage in debates, and contribute to our drive to “Lead the World.”

We look forward to having you join us at ACTA 2020 TOKYO.

Shuichiro Shiina, M.D., Ph.D.
Hosting Chair
Professor of Department of Gastroenterology, Juntendo University

Welcome Message from the Co-Chair
(Immediate Past Hosting Chair)

Sheng-Nan Lu

Dear colleagues:

Hope you doing well in the COVID-19 endemicity!

Tumor ablation is a non-invasive treatment modality for not only liver but also thyroid, kidney, lung, bone and etc. It has been worldwide used, especially in the Asia. The associated fields of tumor ablations are rapid developing, such as ablation apparatus, guidance technology, treatment indications and clinic experience. Therefore, continuous education, communications and collaboration are very important. ACTA is the best platform. Owing to continuous collaboration of all members, Asian Society of Tumor Ablation (ASTA) is getting well organized. Its annual meeting, Asian Conference on Tumor Ablation (ACTA), is the most important activity of ASTA. In the first round, ACTA have been held in Taipei, Fukuoka, Seoul, Guangzhou and Chennai. In 2019, We achieved our task to host the 1st 2nd round ACTA in Chiayi. ACTA is also getting better in these 6 years, including increasing number of participants and experts, enhancing contents of programs, expending fields involved, living demonstration in pre-congress workshops.

I would like to congratulate Prof. Shiina successfully organized this 7th ACTA in Tokyo. And looking forward to your participant.

Sheng-Nan Lu, MD, MPH, PhD
Co-Chair (Immediate Past Hosting Chair)
Deputy Superintendent and
Professor of HepatoGastroenterology
Chiayi Chang Gung Memorial Hospital

Welcome Message from the Co-Chair
(President Elect)

Jung Hwan Baek

Dear colleagues,

It is my greatest honor and pleasure indeed to be elected as the hosting chair of ACTA 2021.

I would like to thank Professor Shuichiro Shiina and the members of organizing committee for their tremendous efforts in organizing ACTA 2020 meeting in Japan. I hope ASTA (Asian Society of Tumor Ablation) leads the cutting-edge opinions in minimally invasive treatment for tumors. Moreover, ASTA will support education for all Aisian doctors in providing the best care for their patients in a form of minimally invasive treatment.

ASTA has successfully held previous annual meetings. I hope that we contribute to continous education and development of guidelines through ACTA 2020.

I am certain that ACTA will continue to grow into one of the leading organizations for minimally invasive treatment world-wide.

I have no doubts that ACTA 2020 in Tokyo, Japan, will be a great success.


Jung Hwan Baek, M.D., Ph.D.
Co-chair (Elected Hosting Chair)
Department of Radiology and Research Institute of Radiology,
University of Ulsan College of Medicine, Asan Medical Center


Early Registration: May. 1 - Jul. 31
Pre-registration: Aug. 1 - Sep. 4
Abstract Submission
Abstract submission has been extended due to the novel coronavirus.


Abstract Submission has been extended.
Online Registration has started.
Abstract submission has been opened.
Call for Abstracts has been updated.
ACTA 2020 Website has opened.


Please include the ACTA2020TOKYO promotional slide in your presentations between now and October 2020. The slide can be easily downloaded by following the below link: